James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30
...Xceed Molecular will feature Ziplex automated gene-expression system a... conference booth 519 ...WELLESLEY Mass. Oct. 28 /- Xceed Molecular a pioneer i... Visitors to the AMP conference will have a great opportunity to hear...
Date:10/28/2008
Xceed Molecular will feature Ziplex automated gene-expression system at the
conference, booth 519
WELLESLEY, Mass., Oct. 28 /PRNewswire/ -- Xceed Molecular, a pioneer in
the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that renowned breast cancer researcher and Xceed
collaborator, Dr. James L. Wittliff, a professor in the Department of
Biochemistry and Molecular Biology at the University of Louisville, will be
a featured speaker at the Association for Molecular Pathology (AMP) Annual
Meeting. Dr. Wittliff's presentation, "Predicting Breast Cancer Outcome
with Gene Expression Signatures on the Ziplex System" is scheduled from 3
to 4 pm on Thursday, October 30, in the Dallas 1-2 Room. The company also
announced that it will feature its award-winning Ziplex Automated
Gene-Expression System at the conference in booth 519. Currently available
for research use only, the Ziplex System is the first integrated system for
automated gene-expression analysis. It comprises an automated hybridization
workstation, TipChip consumable arrays, reagents, and analysis/reporting
software. The AMP 2008 Annual Meeting and Exhibits takes place October 29
through November 2, 2008, at the Gaylord Texan Resort & Convention Center
in Grapevine, Texas.
"Visitors to the AMP conference will have a great opportunity to hear
Dr. Wittliff's presentation on his exciting research predicting risk of
breast cancer recurrence and to learn how the Ziplex System is integral to
his study process," said Xceed's President and CEO, David Deems. "The
Ziplex System is rapidly becoming the standard platform for the nation's
leading institutions performing translational research. Xceed designed the
Ziplex System with turnkey functionality and significant advances in
automation, array format, parallel sample processing, and analytics to
minimize complexity, user interaction, and variability between users and
sites."
Accor
'/>"/>
SOURCE Xceed Molecular Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price2.
Orchid Cellmark Appoints James F. Smith Chief Financial Officer3.
Immunotec Inc. announces appointment of President & CEO James A. Northrop4.
Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence5.
James Webb Space Telescope marks successful completion6.
IRIDEX Announces James Mackaness Will Be Chief Financial Officer7.
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board8.
PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference9.
Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference10.
Warner Chilcott Reports the Death of Its Director James Andress11.
James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
(Date:11/26/2009)..., , WEST LAFAYETTE, Ind. - A new generation of ...chips using tiny structures called semiconducting ...ery by researchers at IBM, Purdue University and t...e researchers have learned how to create nanowires...ly defined at the atomic level, which is a critica...
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - C... Moldt, PhD to its Board of Directors. Dr. Moldt w...entative on the Company,s Board. The number of Boa... "We are very pleased to welcome Peter Moldt to th...perience and guidance as Cytochroma continues to m...
(Date:11/24/2009)..., , HOUSTON, Nov. 24 /PRNewswire-Firs... provider of electrical and communications systems...esidential markets, announced today that its comme...rom Manhattan Torcon JV to install the electrical ...lacement facility at the U.S. Army Medical Researc...
(Date:11/24/2009)..., , REYKJAVIK, Iceland, ...ics, Inc. (Nasdaq: DCGN ) today announced that it ...hat trading in the company,s common stock will be,...E will be filed with the,Securities and Exchange C...,from listing on Nasdaq, unless the company files ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3... which company,stood out at last week,s ASCO confe...he top of the list, according to AlphaDetail, Inc.... influence network mapping solutions,to the Global...ey of 103 oncologists conducted soon after the,clo...er some interesting,feedback about oncologist perc...
...for Removal of Clinical Hold, BERKELEY HEIGHTS, N...rd: GNTA) announced that the Company has,received ...e European,Patent Office for its pipeline product,...ate to composition of matter for the tesetaxel dru...e Company plans to broadly,secure validation of th...
...chnology to Lexicon Targets, COPENHAGEN, June 10 ...nce with Lexicon Pharmaceuticals, Inc. (Nasdaq: L...le lead compounds for highly,validated drug target...s proprietary Chemetics(R),drug discovery technolo...e,lead compounds against a range of drug targets p...
Other Biology Technology:ASCO Results: Oncologists Rank Genentech Number One 2Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 2Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 4Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 2Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 3...about 45,000 square kilometers worldwide--about th...ts, tidal marshes support few nonaquatic vertebrat...ed to the evolution of species and subspecies that...pecies and subspecies, which seem to be largely re...uit them to life in a harsh environment in which s...
...suaded from the object of their attention by a pie...ind new treatments and cures for human disorders l...t time, a psychiatric test for monitoring many hum...n mice, according to researchers at Purdue Univers...big University in Giessen, Germany. The test invol...
...t role in the formation of gold nuggets in Austral...in the international journal, Science .. , The p...arch Centre for Landscape Environments and Mineral...r, Frank Reith. , Dr Reith,s research has shown ...tion of secondary gold grains. , His study of go...
Other Biology News:Species unique to tidal marshes face threats 2Mice learn tasks that may help treat human psychiatric disorders 2Mice learn tasks that may help treat human psychiatric disorders 3The Midas Bug -- the bacterial alchemy of gold 2801 Rotor System with 305/315, 6 50 ml Falcon/Corning from Thermo Scientific
Smart Scan 96 from ABgene
... drives of VARIOMAG Magnetic Stirrers operate with...hanical bearings, making VARIOMAG Magnetic Stirrer..., the VARIOMAG inductive drive can be hermetically...microorganisms. This is why VARIOMAG Magnetic Stir...
Crimp Seals with PTFE/Rubber Septa from Sigma-Aldrich
Biology Products: